Stock TAK N TAKEDA PHARMACEUTICAL COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Takeda Pharmaceutical Company Limited Mexican S.E.

Equities

TAK N

US8740602052

End-of-day quote Mexican S.E.
Other stock markets
 18:00:00 2024-06-19 EDT 		5-day change 1st Jan Change
231.5 MXN -3.73% Intraday chart for Takeda Pharmaceutical Company Limited 0.00% -3.42%
06-25 US CDC alerts healthcare providers of increase in dengue cases RE
06-25 Takeda's Cancer Drug Gets European Commission Approval MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Takeda Pharmaceutical Company Limited Announces Demise of its Board Member, Olivier Bohuon
CI
Takeda Pharmaceutical Names Milano Furuta as Chief Financial Officer
MT
Antisense Therapeutics Appoints CEO/Managing Director
MT
Takeda Pharmaceutical Company Limited Announces Board Changes
CI
Takeda Pharmaceutical Company Limited Announces Masato Iwasaki, Representative Director Expresses His Intention to Retire on June 28Th
CI
Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO
AN
Takeda Pharmaceutical Company Limited Announces New Assignments of Directors
CI
Takeda Pharmaceutical Company Limited Announces Board Appointments
CI
OncoSec Medical Names Robert Arch CEO; Shares Rise Early
MT
Takeda Pharmaceutical Company Limited Announces Executive Changes
CI
Former Takeda vaccine chief to lead new COVID antiviral venture Aerium
RE
Takeda Announces Management Changes
CI
Takeda Announces New Assignments of Directors
CI
Takeda Pharmaceutical Company Limited Announces Retirement of Yasuhiko Yamanaka as Director and Member of Audit and Supervisory Committee
CI
Takeda Announces Directorate Changes
CI
Takeda Pharmaceutical Company Limited Announces Executive Changes
CI
Nabriva Therapeutics : Names Daniel Dolan CFO
MT
Takeda Pharmaceutical : Rute Fernandes Appointed General Manager of Takeda Canada
AQ
Takeda Pharmaceutical : Named Global Top Employer for Fourth Consecutive Year
PU
Takeda Appoints Ebru Yavuz as CEO of Newly Formed Ukraine and CIS Cluster
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4502 Stock
  4. TAK N Stock
  5. News Takeda Pharmaceutical Company Limited
  6. Insiders